STOCKS | Sino Biopharmaceutical Unit Sees H1 Net Profit Rise At Least 217.2%

Sihuan Pharmaceutical Holdings expects net profit for the six months ended June 30, 2026 to be no less than RMB 210 million, up at least 217.2% from a year earlier, according to Ming Pao. The company also said revenue is expected to be at least RMB 1.14 billion, broadly unchanged from the same period last year.